Ocular Therapeutix, Inc. (OCUL)
8.52
+0.23
(+2.77%)
USD |
NASDAQ |
May 27, 15:45
Ocular Therapeutix Cash from Investing (Quarterly) : -4.662M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| EyePoint, Inc. | 59.05M |
| Merck & Co., Inc. | -10.21B |
| Zevra Therapeutics, Inc. | 79.62M |
| Axsome Therapeutics, Inc. | -0.121M |
| Bristol Myers Squibb Co. | -131.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -65.99M |
| Cash from Financing (Quarterly) | 0.294M |
| Free Cash Flow | -240.94M |
| Free Cash Flow Per Share (Quarterly) | -0.3153 |
| Free Cash Flow to Equity (Quarterly) | -73.15M |
| Free Cash Flow to Firm (Quarterly) | -67.88M |
| Free Cash Flow Yield | -14.08% |